You are here

  • Home
  • Archive
  • Volume 80, Issue 1
  • Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study

Article metrics

Article menu
XML
Recommendation
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study

 

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

AbstractFullPdf
Jul 202013331310368
Aug 2020631615333
Sep 2020173170117
Oct 202010801078262
Nov 2020400397146
Dec 2020594593243
Jan 2021400388219
Feb 2021231223137
Mar 2021218210159
Apr 2021159156140
May 2021140139107
Jun 202112412889
Jul 202111511986
Aug 2021939467
Sep 202115715366
Oct 202115014783
Nov 202111411669
Dec 202113212684
Jan 2022888251
Feb 202212812944
Mar 202211712161
Apr 2022939650
May 2022848343
Jun 2022677145
Jul 2022656734
Aug 2022737270
Sep 2022686942
Oct 2022939641
Nov 2022717037
Dec 2022504927
Jan 2023343220
Feb 2023605619
Mar 2023454130
Apr 2023363636
May 2023423823
Jun 2023565343
Jul 2023535232
Aug 2023424036
Sep 2023413525
Oct 2023495026
Nov 2023453615
Dec 2023514924
Jan 20241136733
Feb 2024343113
Mar 2024714354
Total801378263749